Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I added a lot of shares yesterday and the day before just below .51. I’m very happy :)
Check this out, Tryn2:
Hey Inquirig, there is no point arguig with you because you are pursuig wrong motives and assumig that others can’t see it. Your posts are however amusig and without any reasonig. I hope my argument is convincig and not annoyig. I don’t want to come across as irritatig.
You're very welcome.
Cheers,
BB
Your suggested pathway is exactly what I did to receive my certificates and place them with my family's Trust Company.
Cheers,
BB
Thanks, Senti .very good instructions and very supportive of Northwest Bio as always!!
Cheers,
BB
Yeah...got my additional shares at .50....it took 3 hours.
Every passing day is a day closer...and the beat gets louder...Let's hope for positive news soon. Very soon!!
George,
Safety is always over convince. Don't think the dark forces have no soul and they corrupt the system. Should Harvard do some background check on Ken Griffin before taking his money? Obviously not.
NWBO longs are complaining about low share price. I think if 10% or 25% of retailers start holding certificate the sp could take off right away.
It's only for the long and strong! I didn't buy the stock to trade it.
Cheers,
BB
Never hurts to try!
Just in time for the MHRA rejection
Now I start thinking that you may be a wolf in sheep skin.
So my Horoscope gave me good news...."You’ll reconsider your solo endeavors on April 1, as Mercury stations retrograde in Aries. Though you’re used to initiating new projects without too many delays or setbacks, you’ll be prompted to head back to the drawing board regarding any pursuits that place you at the center. Now isn’t the time to jump the gun; instead, think your plans through! You’ll feel more confident about what you’re pursuing once Mercury stations direct on April 25."
NWBO longs should take this post seriously. If you believe the system is working, the system may fail you in the end. Seriously, if the system were working, DCVax-L should have been available long time ago and tens of thousands of lives, especially many children's lives could have been saved. What kind of huge stakes could possibly make Harvard professor abandon ethic rules and write a hitting piece published on the Thanksgiving day?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174269450
Does everyone know the meaning of Fails-to-deliver?
https://www.sec.gov/comments/s7-07-23/s70723-20162302-331156.pdf
Definitely the mechanics.
The electronics for this are nothing. a control system with a few dozen inputs and a small number of outputs plus coms.. Once you have a concrete design there are thousands of companies that will build tested circuit boards for you at a modest cost. If they were cost sensitive they could probably get the COGS for a tested board under $100.
Oh, and nobody would build this with either "programmable microchips" or a PLA. It would be a vanilla setup with an Arm SOC and eMMC. The crap one poster here has been talking about has been obsolete in this space for 2 decades.
For disposables, the only issue is the one time setup cost. That may not be chump change.
That's almost funny, for a misogynist.
BTW, your stock is about to break $0.50 cents and head towards the $0.30s
There goes Fonzi and in comes Glen Miller.
Love the 40s
Senti yes on the Roth- I can’t sell those for 2 and 3 years so I may as well get the certificate. I also thought this might be complicated as it seemed to me that a Roth certif would need to be documented as such to maintain tax status.
For rubes like myself, with no real financial or investment training whatsoever, the way forward is completely unknown.... I gave my money in good faith that the financial institutions (Scottrade, TDA, and now Schwab) that I gave my money to, would provide actual shares, or at least sell my fake shares to someone else just like the fake shares were sold to me, and accept the financial responsibility for them when THEY aquired them for me.... when the entire group of institutions that buy and sell equity in publically traded companies are crooks, what do you do??? At least if you win money at a casino, they give you the money you won.... all these crooks will be pointing at each other....
Get your orders in bishes..
Last chance to buy high before the $0.20s are here.
It’s a bit more complicated than that if your DRS shares are issued less then 6 months.
In that case, you need to ask your broker a « Broker representation Letter » and then after ask a lawyer for a « legal letter » to approve the shares are yours and submit it to the transfer agent.
Then, the transfer agent will contact your broker and transfer the shares in your account.
Not impossible because I’ve done that in the past (not with my shares of NWBO) but not an easy task tbh.
Fidelity will likely take them. They will take NWBO shares transferred from Computer Share.
Again, though, this is NOT an action I’d recommend for anyone using a Roth account. And I think quite a few of us are using those.
Schwab doesn’t allow the transfer in of any OTC stocks. Schwab will allow you to buy OTC stocks with them; but when you do, they place warnings of those buys. Perhaps they feel that because they’ve warned you, you do so at your own peril.
senti,
The biggest concern should be safety. You aren't saying no broker will take paper certificates, are you? If Schwab will not take them, we can always find another one.
Of course if you have your shares in a physical form, you will securely own those shares. But because the market no longer buys and sells shares in that form (paper certificates), it’s my belief that you’ll have to give them back to one of these companies (Schwab, Fidelity) in order to sell any of them, in the event that you might want to. And I don’t think Schwab will take them back, as an OTC stock.
Protecting their customer's accounts
BB,
Thank you for the reminder.
Sorry, my English is probably on elementary school level. If you say something deep, put it as simple as possible.
I'm not a stock expert but can NWBO get an official count of shares if they request? The 1 cent dividend would solve this problem wouldnt it?
Hardest to easiest, imo
Mechanical features
Disposable parts
E-Proms
senti,
What are you talking about? You don't think we know this. Level with me: Do we have security for our shares at least if we do what BB suggested?
Cannot you sense how low these dark forces? Their lawyers even had the audacity using vacation as excuse. These dark forces pushed NWBO to the OTC in the thought that the company would become extinct sooner or later and all their dirty records would disappear without trace. You don't think there are enormous number of fake shares?
Senti - Do you understand the reasoning behind these?
To continue on this thought, please let us know if this works out differently for you.
One area where this would likely present a problem is when these shares are kept in a Roth account, as I don’t believe you can just remove those shares, and then put them back.
Once an original Eden prototype is selected, what is harder to mass produce, the mechanical features, the disposable parts or the programmed microchips?
Yep Schwab kind of sucks. They pay paultry and then they do these kind of things. . Stick with Fidelity in my opinion.
Agree and second you senti. Better call your brokerage and remove your margin flexibility if it was silently attached to your account when you opened and you never took margin money from your brokerage. In any CASE I WOULD CALL MY BROKERAGE AND MAKE SURE they don't lend out my nwbo shares; I kept receiving calls and emails from my brokerage Fidelity asking me to lend them, but I said a strict No. The reason is they won't release your shares when you need them; say, in a MOASS which can be a done deal several times with this stock some day(s). Go NWBO!
On April 27, 2024 all will be revealed.
Let me ask you a quick question: Did you try it with Fidelity?
I don’t believe these entities can present you with paper certificates. I think they can transfer them to Computer Share, who can them give them to you in a physical form. At that time, then, they are no longer available in the market to be bought or sold, which is fine, I suppose, if that is your intent. Then if you wish to put these shares back into the market, you will likely have trouble doing so at Schwab as they currently do not accept transfers of NWBO into their accounts. You can purchase NWBO through them, but you can’t transfer shares in. Perhaps they will allow those back that you’d originally bought with Schwab, but that can be a month(s) long process. Fidelity will take them, though.
That’s my understanding of the process, via my own past experience with Schwab.
you just never know who knows who, and who knows what. Its a very small world.
A bit more if you want to sell:
If you have a DRS Statement and you would like to sell your shares, you must deliver the statement, together with any other required documents, to your broker and arrange for your broker to sell your shares. If you do not have an account with a broker, you will have to open one. There may be a fee to open an account.
As you can see, if company XYZ was a .51 per common, and we woke up and at 9:30am it was trading at $3.50, you just cant until the lot you want to sell, click a button and make profit. All within 3) seconds or less. If you have DRS shares it all has to be pre-arranged a day or two or three in advance. Is that what you really want? Its a HARD pass for me for too many reasons to list here.
You will never get them, at least not from Fidelity. Its not as easy as a phone call and they issue your certs. It a long, confusing process, Once you get your name on DRS, they are no longer even held at Fidelity. So when you want to sell them, the process is even more confusing. Dont lead other investor's down a path unless you know the facts of the situation you are speaking of. See below:
Fidelity can only issue certificates for securities that are not eligible to participate in the Direct Registration System (DRS). DRS allows electronic direct registration of securities in an investor's name in book-entry form with the issuer or the issuer's transfer agent. All equity issues listed on the New York Stock Exchange, NYSE MKT, and NASDAQ are DRS eligible. If a company does not participate in DRS, Fidelity can issue a certificate for shares held in a nonretirement brokerage account for a fee of $100 per certificate. If you would like a certificate for a DRS eligible security, you will first need to request to have your shares transferred. Fidelity does not charge a fee for DRS transfers. Now, the Direct Registration System (DRS) allows you to directly register shares you own in book-entry form with the issuer or the issuer's transfer agent. Clients can choose to DRS shares for eligible securities, but note that a security's status as Expert Market does not require the shares to be transferred.
DRS shares are no longer held at Fidelity, and the issuer or transfer agent becomes responsible for dividend and interest payments, proxies, annual report mailings, account statements evidencing ownership of the security, and other record keeping and transactions for the security going forward. You'll want to connect with the issuer or transfer agent for further insight into what actions you'll be able to take for DRS shares.
Don't expect anything detailed.
Will most likely be general statements about the vaccine.
She could also mention her own ongoing trials and maybe make a distinction between DCVAX and ALT or a number of other issues. She is an SA now so it could be interesting.
We will see, but I doubt that.
The book written on this one will include a chapter on management's (or warrant holders or both??) total mastery of social media. There are armies of retail followers on X and other platforms with barely one soldier ever expressing any concerns. It's truly a thing to behold.
All 50 + thousand Northwest shareholders, listen up, Please! I have requested that TD Ameritrade, Schwab and Fidelity provide actual share certificates for all the shares I have purchased in the open market. With all the naked shorting and spoofing, not a single one of us really know if all we own is a DTCC number or the actual certificates behind the Cusip #. Short of the certificate(Pun intended cause that's exactly what happens when we buy a stock and get a number without the paper behind it), all we have is the "good faith and credit" of the brokerage firm and if there are counterfit shares... and a short squeeze occurs, it will cost you a fortune plus 100 years to sue to get your shares, if ever.
I'm not being an alarmist, just suggesting that everyone take care of business and protect what they own before the "Crims" tell you that they've been naked shorting and never intended to cover. Buyer beware or Buyer gets screwed!! Also, if all Northwest shareholders request certificates, the requests that match the company's share register will receive certificates and those that don't match will certainly tell us how many naked shorts are out there!!!
Cheers,
BB
She will most likely promote the UCLA early trials and maybe give a slight mention of the DCVAX application.
These people are very careful about what they say in public.
The company is the only seller at this point and they have pumpers out there to try and get you folks to buy their shares.
Other than that , there is no action until news released about MHRA
Followers
|
1619
|
Posters
|
|
Posts (Today)
|
180
|
Posts (Total)
|
688652
|
Created
|
02/02/05
|
Type
|
Free
|
Moderators XenaLives sentiment_stocks CaptainObvious Poor Man - Doc logic JerryCampbell |
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.”
~ Winston Churchill
Stylized Dendritic Cell featured on NWBO board since 2015
- Dr. Linda Liau, PhD, MBA, Professor and Chair, Department of Neurosurgery, David Geffen School of Medicine at UCLA
Clinical Trials
DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind)
UK (MHRA): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
DE (Germany - PEI): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access)
Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label)
UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer
EU Clinical Trials for DCVax-L - Phase III
Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA - Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC
Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873)
Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma - Phase 2 (NCT03014804)
Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer (NCT0368765) - Phase 1 - Collaborator: Mayo Clinic
Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial - November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz
Cognate Bioservices - Owned by Charles River Labs
Website
Company Contact Info
Investor Relations:
Les Goldman (Company) (202) 841-7909 lgoldman@nwbio.com
Sign up for Northwest email list here (hit the subscribe to email list button in the lower right)
Company Headquarters
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814 (240) 497-9024
NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables them to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines.
Their lead product, DCVax-L, is currently in a 331-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.
Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.
They previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.
DCVAX Survival Stories & Testimonials
Alice - Metastic Merkel Cell patient from Florida - ASCO 2018
Brad Silver - GBM patient from Huntington Beach, California - ASCO 2018
Sarah Rigby - GBM patient from Hong Kong - ASCO 2018
Kristyn Power - daughter of GBM patient from Canada - ASCO 2018
Kat Charles - GBM patients from UK - ASCO 2018 - as related by her husband Jason (Kat's Cure)
Prospective patients may contact NW Bio at patients@nwbio.com
UCLA Jamil Newirth DCVax-Patient Video - 2015
Allan Butler Video - National Geographic Vice President - DCVax-Direct patient from Phase 1 Trial with Pancreatic Cancer
NWBO - Patients Sunday Dennis and Jami Newirth - Enrolled at UCLA - Vimeo, Uploaded approx. May 2015
NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015
NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson
NWBO GBM Brain Cancer Survival Story of Mark Pace
Presentations
UCLA Agreements
Prostrate
DCVax-Phase II
DCVax-Booster
Upcoming Events
Videos
Linda M. Liau, MD, PhD, MBA - April 24, 2019 at University of Washington, Neurosciences Institute
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |